Zeria Pharmaceutical Co (TSE:4559) Cyclically Adjusted Book per Share: 円1,573.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4559 Zeria Pharmaceutical Co Ltd TSE:4559
85 GF Score
Price 円2,087.00
GF Value 円2,506.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zeria Pharmaceutical Co Cyclically Adjusted Book per Share?

Zeria Pharmaceutical Co TSE:4559 +1.61% 85 Cyclically Adjusted Book per Share is 円1,573.16 as of Mar. 2026. GuruFocus rates TSE:4559 with a GF Score™ of 85/100 and a GF Value™ of 円2,506.68 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zeria Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was 円2,459.147. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円1,573.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zeria Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zeria Pharmaceutical Co was 8.40% per year. The lowest was 5.40% per year. And the median was 7.05% per year.

As of today (2026-07-21), Zeria Pharmaceutical Co's current stock price is 円2087.00. Zeria Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円1,573.16. Zeria Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.33.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zeria Pharmaceutical Co was 2.67. The lowest was 1.27. And the median was 1.82.


Zeria Pharmaceutical Co  (TSE:4559) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zeria Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2087.00/1573.16
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zeria Pharmaceutical Co was 2.67. The lowest was 1.27. And the median was 1.82.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zeria Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zeria Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zeria Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,151.79 1,251.84 1,350.60 1,468.54 1,573.16

Zeria Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,468.54 1,493.63 1,516.53 1,550.33 1,573.16

TSE:4559 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zeria Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zeria Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zeria Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zeria Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4559
85GF Score
Zeria Pharmaceutical Co Ltd TSE:4559
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeria Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zeria Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2459.147/112.7000*112.7000
=2,459.147

Current CPI (Mar. 2026) = 112.7000.

Zeria Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 1,206.900 98.100 1,386.520
201609 1,131.517 98.000 1,301.245
201612 1,103.234 98.400 1,263.562
201703 1,192.728 98.100 1,370.239
201706 1,153.480 98.500 1,319.768
201709 1,191.393 98.800 1,359.008
201712 1,213.093 99.400 1,375.408
201803 1,300.866 99.200 1,477.899
201806 1,299.746 99.200 1,476.627
201809 1,280.641 99.900 1,444.727
201812 1,273.440 99.700 1,439.485
201903 1,235.092 99.700 1,396.137
201906 1,210.854 99.800 1,367.367
201909 1,191.369 100.100 1,341.332
201912 1,180.262 100.500 1,323.538
202003 1,134.307 100.300 1,274.540
202006 1,147.364 99.900 1,294.374
202009 1,157.265 99.900 1,305.543
202012 1,180.921 99.300 1,340.280
202103 1,225.087 99.900 1,382.055
202106 1,207.433 99.500 1,367.615
202109 1,246.910 100.100 1,403.864
202112 1,228.222 100.100 1,382.823
202203 1,236.087 101.100 1,377.913
202206 1,286.974 101.800 1,424.774
202209 1,395.016 103.100 1,524.911
202212 1,489.117 104.100 1,612.137
202303 1,484.798 104.400 1,602.842
202306 1,522.301 105.200 1,630.830
202309 1,717.403 106.200 1,822.517
202312 1,780.158 106.800 1,878.500
202403 1,806.319 107.200 1,898.994
202406 1,858.709 108.200 1,936.012
202409 2,002.451 108.900 2,072.325
202412 1,929.665 110.700 1,964.528
202503 2,031.303 111.100 2,060.557
202506 1,983.648 111.700 2,001.407
202509 2,079.704 112.000 2,092.702
202512 2,178.228 113.000 2,172.445
202603 2,459.147 112.700 2,459.147

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円1,573.16 mean?
Zeria Pharmaceutical Co (TSE:4559) has a Cyclically Adjusted Book per Share of 円1,573.16 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zeria Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円1,573.16. Overall, Zeria Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Zeria Pharmaceutical Co's Cyclically Adjusted Book per Share of 円1,573.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円1,573.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,506.68, compared to a current price of 円2,087.00 — trading 16.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円1,573.16. Zeria Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current Cyclically Adjusted Book per Share is 円1,573.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?

Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,087.00 is trading 16.7% below its estimated GF Value™ of 円2,506.68. GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4559:

  • Cyclically Adjusted Book per Share: 円1,573.16
  • GF Value™: 円2,506.68 vs. price of 円2,087.00 (16.7% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zeria Pharmaceutical Co Business Description

Address 10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
85GF Score

Get the complete analysis for TSE:4559

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,087.00
Price
円2,506.68
GF Value